Research and Markets: 2015 Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market

Research and Markets (http://www.researchandmarkets.com/research/vbd7sr/2015_strategies) has announced the addition of the "2015 Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market" report to their offering.

This new 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.

Companies Mentioned:

- Abbott

- ADI/America Diagnostica

- Agilent Technologies

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomerieux

- Bio-Rad

- Biosite/Inverness/Alere

- Cepheid

- Chrono-Log

- Corgenix

- Decode

- Eiken Chemical

- EKF Diagnostics

- Fujirebio/Innogenetics

- Helena Laboratories

- Hologic/Gen-Probe

- Horiba

- Instrumentation Laboratory

- International Technidyne/Nexus DX

- Kreatech

- Kyowa Medex

- Life Technologies

- Lonza

- Ortho-Clinical Diagnostics

- Polartechnics

- Polymedco

- Qiagen

- Roche

- Sequenom

- Siemens

- Sienco

- Sysmex

- Takara Bio

- Zycare/Alere

For more information visit http://www.researchandmarkets.com/research/vbd7sr/2015_strategies

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.